Lista de obras - Vernon Harvey - Dominio Público Uruguay

A durable complete remission between two isolated presentations of metastatic breast cancer, the second with intracardiac disease

artículo científico publicado en 2006

A phase II study of tamoxifen in ovarian cancer

artículo científico publicado en 1986

A prospective study of cisplatin-based combination chemotherapy in advanced germ cell malignancy: role of maintenance and long-term follow-up

artículo científico publicado en 1988

A randomized comparison of single-agent doxorubicin and epirubicin as first-line cytotoxic therapy in advanced breast cancer

artículo científico publicado en 1991

A randomized phase II study comparing capecitabine alone with capecitabine and oral cyclophosphamide in patients with advanced breast cancer-cyclox II

scientific article published on 04 March 2013

A randomized trial comparing vindesine and cisplatinum to vindesine and methotrexate in advanced non small cell lung carcinoma

artículo científico publicado en 1987

Adjuvant Letrozole and Tamoxifen Alone or Sequentially for Postmenopausal Women With Hormone Receptor-Positive Breast Cancer: Long-Term Follow-Up of the BIG 1-98 Trial

scientific article published on 26 November 2018

Adjuvant bevacizumab-containing therapy in triple-negative breast cancer (BEATRICE): primary results of a randomised, phase 3 trial

artículo científico publicado en 2013

Adjuvant chemotherapy for non-metastatic osteosarcoma of the extremities in two New Zealand cancer centres

artículo científico publicado en 1995

Adjuvant oral Razoxane (ICRF 159) in resectable colo-rectal cancer

artículo científico publicado en 1983

Adjuvant therapy of colon cancer: what should we be doing

artículo científico publicado el 10 de julio de 1991

Antiemetic effect of nonabine in cancer chemotherapy

artículo científico publicado en 1983

Bias in survival estimates created by a requirement for consent to enter a clinical breast cancer registry

scientific article published on 1 February 2019

Bilateral germ cell testicular tumors in New Zealand: experience in Auckland and Christchurch 1978-1994

artículo científico publicado en 1996

Bleomycin and mild renal failure

artículo científico publicado en 1986

CYP19A1 polymorphisms and clinical outcomes in postmenopausal women with hormone receptor-positive breast cancer in the BIG 1-98 trial

artículo científico publicado en 2015

Capecitabine Versus Classical Cyclophosphamide, Methotrexate, and Fluorouracil As First-Line Chemotherapy for Advanced Breast Cancer

article

Cerebral metastases in patients with ovarian cancer treated with chemotherapy

scientific article published on 01 June 1989

Chemotherapy of diffuse malignant mesothelioma. Phase II trials of single-agent 5-fluorouracil and adriamycin

scientific article published on 01 September 1984

Cisplatin combination chemotherapy versus chlorambucil in advanced ovarian carcinoma: mature results of a randomized trial.

artículo científico publicado en 1985

Clinical applications of receptor measurements in breast cancer

artículo científico publicado en 1980

Clinical aspects of a phase I trial of 5,6-dimethylxanthenone-4-acetic acid (DMXAA), a novel antivascular agent

scientific article published on June 2003

Clinical behavior of recurrent hormone receptor-positive breast cancer by adjuvant endocrine therapy within the Breast International Group 1-98 clinical trial

scientific article published on 08 December 2020

Cognitive function in postmenopausal breast cancer patients one year after completing adjuvant endocrine therapy with letrozole and/or tamoxifen in the BIG 1-98 trial

artículo científico publicado en 2010

Cognitive function in postmenopausal women receiving adjuvant letrozole or tamoxifen for breast cancer in the BIG 1-98 randomized trial

artículo científico publicado en 2010

Comparison of Subcutaneous and Intravenous Administration of Trastuzumab: A Phase I/Ib Trial in Healthy Male Volunteers and Patients With HER2-Positive Breast Cancer

artículo científico publicado en 2013

Comparison of subcutaneous and intravenous administration of trastuzumab: a phase I/Ib trial in healthy male volunteers and patients with HER2-positive breast cancer

artículo científico publicado en 2013

Comparison of two standard chemotherapy regimens for good-prognosis germ cell tumors: updated analysis of a randomized trial.

artículo científico publicado en 2010

Comparison of two standard chemotherapy regimens for good-prognosis germ-cell tumours: a randomised trial. Australian and New Zealand Germ Cell Trial Group.

artículo científico publicado en 2001

Cumulative incidence of cardiovascular events under tamoxifen and letrozole alone and in sequence: a report from the BIG 1-98 trial

artículo científico publicado en 2020

Curable chemotherapy

artículo científico publicado en 1987

Delayed-release bleomycin. Comparative pharmacology of bleomycin oil suspension and bleomycin in saline

scientific article published on 01 January 1984

Development and validation of a new predictive model for breast cancer survival in New Zealand and comparison to the Nottingham prognostic index

article

Differences in Breast Cancer Survival between Public and Private Care in New Zealand: Which Factors Contribute?

artículo científico publicado en 2016

Disease relapse in patients with stage I nonseminomatous germ cell tumor of the testis on active surveillance

artículo científico publicado en 1988

Do men undergoing sterilizing cancer treatments have a fertile future?

artículo científico publicado en 1998

Dose intensity and outcome with combination chemotherapy for germ cell carcinoma. Australasian Germ Cell Trial Group

artículo científico publicado en 1989

Dose-intense weekly cyclophosphamide, methotrexate, 5-fluorouracil, vincristine and prednisolone (CMFP) in advanced breast cancer

artículo científico publicado en 1990

ESR1 and ESR2 polymorphisms in the BIG 1-98 trial comparing adjuvant letrozole versus tamoxifen or their sequence for early breast cancer

artículo científico publicado en 2015

Effect of Adjuvant Trastuzumab for a Duration of 9 Weeks vs 1 Year With Concomitant Chemotherapy for Early Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: The SOLD Randomized Clinical Trial

scientific article published on 01 September 2018

Effect of dose and schedule on pharmacokinetics of high-dose cytosine arabinoside in plasma and cerebrospinal fluid

artículo científico publicado en 1983

Effect of pregnancy on overall survival after the diagnosis of early-stage breast cancer.

artículo científico publicado en 2001

Effective salvage chemotherapy with etoposide, dactinomycin, and methotrexate in refractory germ cell cancer. Australasian Germ Cell Trial Group

artículo científico publicado en 1990

Effects of CI-921, an analogue of amsacrine, on advanced Lewis lung tumours in mice: relevance to clinical trials

artículo científico publicado en 1988

Ethnic disparities in breast cancer survival in New Zealand: which factors contribute?

artículo científico publicado en 2018

Evaluating and designing cancer chemotherapy treatment using mathematical models.

artículo científico publicado en 1986

Experience with an implantable venous access system for chemotherapy

artículo científico publicado el 10 de julio de 1991

Follow up of breast cancer patients

artículo científico publicado en 1996

Gefitinib treatment in hormone-resistant and hormone receptor-negative advanced breast cancer.

artículo científico publicado en 2009

Guidelines for the use of granulocyte colony stimulating factor (G-CSF)

HCG--choosing the best assay to monitor gestational trophoblastic disease and other germ cell tumours

artículo científico publicado en 1993

High-performance liquid chromatography of etoposide in plasma and urine

Improving the quality of life during chemotherapy for advanced breast cancer. A comparison of intermittent and continuous treatment strategies.

artículo científico publicado en 1987

Late results of surveillance of clinical stage I nonseminoma germ cell testicular tumours: 17 years' experience in a national study in New Zealand

artículo científico publicado en 1999

Late seminomatous relapse of a mixed germ cell tumor of the testis on intensive surveillance

artículo científico publicado en 1995

Long-term efficacy analysis of the randomised, phase II TRYPHAENA cardiac safety study: Evaluating pertuzumab and trastuzumab plus standard neoadjuvant anthracycline-containing and anthracycline-free chemotherapy regimens in patients with HER2-posit

artículo científico publicado en 2017

Maternal transmission of hepatocellular carcinoma

artículo científico publicado en 1984

Medical resource utilization for administration of trastuzumab in a New Zealand oncology outpatient setting: a time and motion study

artículo científico publicado en 2015

Mitozantrone-induced onycholysis.

artículo científico publicado en 1992

Neratinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer (ExteNET): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

artículo científico publicado en 2016

Oncology Centre--a medical view

artículo científico publicado en 1987

Ondansetron reduces chemotherapy induced nausea and vomiting refractory to standard antiemetics

artículo científico publicado el 11 de marzo de 1992

Overall survival benefit for sequential doxorubicin–docetaxel compared with concurrent doxorubicin and docetaxel in node-positive breast cancer—8-year results of the Breast International Group 02-98 phase III trial†

artículo científico publicado en 2013

Overall survival from breast cancer in women pregnant or lactating at or after diagnosis. Auckland Breast Cancer Study Group

artículo científico publicado en 1996

PIK3CA alterations and benefit with neratinib: analysis from the randomized, double-blind, placebo-controlled, phase III ExteNET trial

article

PO6 Consolidation of the four New Zealand breast cancer registers

artículo científico publicado en 2018

Palliation of biliary obstruction in patients with advanced breast cancer using endoscopic stents ⬇️

artículo científico publicado el 1 de septiembre de 1993

Patient assessment of a combined medical and nursing preparation to cytotoxic chemotherapy

scientific article published on 01 July 1993

Pertuzumab plus trastuzumab in combination with standard neoadjuvant anthracycline-containing and anthracycline-free chemotherapy regimens in patients with HER2-positive early breast cancer: a randomized phase II cardiac safety study (TRYPHAENA)

artículo científico publicado en 2013

Phase I study of the cytotoxic agent N-[2-(dimethylamino)ethyl]acridine-4-carboxamide

artículo científico publicado en 1999

Phase I trial of the amsacrine analogue 9-[( 2-methoxy-4-[(methylsulfonyl)amino]-phenyl]amino)-N,5-dimethyl-4- acridinecarboxamide (CI-921)

artículo científico publicado en 1988

Phase II study of efficacy, safety, and pharmacokinetics of trastuzumab monotherapy administered on a 3-weekly schedule

artículo científico publicado en 2005

Phase II study of the amsacrine analogue CI-921 (NSC 343499) in non-small cell lung cancer

artículo científico publicado en 1991

Phase II study of vinblastine and bleomycin in advanced ovarian cancer

scientific article published on 01 March 1987

Phase II trial of procarbazine, vincristine and lomustine (POC) chemotherapy in metastatic cutaneous malignant melanoma

artículo científico publicado en 1994

Phase III Trial Comparing Three Doses of Docetaxel for Second-Line Treatment of Advanced Breast Cancer

artículo científico publicado en 2006

Predicting nonadherence to adjuvant endocrine therapy in women with early stage breast cancer

artículo científico publicado en 2018

Pregnancy after treatment of endodermal sinus tumour. Case report with five-year survival

scientific article published on 01 September 1982

Pregnancy and breast cancer

Qualitative assessment of the progesterone receptor and HER2 improves the Nottingham Prognostic Index up to 5 years after breast cancer diagnosis

artículo científico publicado en 2010

Quality-of-life valuations of advanced breast cancer by New Zealand women

artículo científico publicado en 2006

Re: The relationship between serum alkaline phosphatase and vincristine neuropathy

scientific article published on 01 January 1983

Reduction of carboplatin induced emesis by ondansetron ⬇️

artículo científico publicado el 1 de junio de 1991

Reply to: letter to the editor "subcutaneous herceptin therapy"

scientific article published on 21 September 2013

Research and patient care: what needs review and by whom?

scientific article published on 01 May 1989

Results of the surveillance policy of stage I non-seminomatous germ cell testicular tumours

artículo científico publicado el 1 de octubre de 1992

Serum insulin-like growth factor-I and insulin-like growth factor binding protein-3 following chemotherapy for advanced breast cancer ⬇️

artículo científico publicado el 1 de noviembre de 2003

Small-cell lung carcinoma: Survival after combination chemotherapy, radiotherapy or symptomatic treatment ⬇️

artículo científico publicado el 1 de octubre de 1983

Stage of breast cancer at diagnosis in New Zealand: impacts of socio-demographic factors, breast cancer screening and biology

artículo científico publicado en 2016

Studies of the Australasian Germ Cell Trial Group: the management of advanced testis cancer

artículo científico publicado el 1 de enero de 1990

Subcutaneous infusion of bleomycin--a practical alternative to intravenous infusion.

artículo científico publicado en 1987

Subjective cognitive complaints one year after ceasing adjuvant endocrine treatment for early-stage breast cancer

artículo científico publicado en 2012

Survival of women with node negative breast cancer in the Auckland region

scientific article published on 01 September 1996

Tamoxifen in refractory ovarian cancer: the use of a loading dose schedule

artículo científico publicado en 1988

The Auckland Breast Cancer Register: a special project of the Auckland Breast Cancer Study Group

artículo científico publicado el 24 de octubre de 2003

The acquired immunodeficiency syndrome in Auckland in 1985

artículo científico publicado en 1986

The antiemetic activity of tetrahydrocannabinol versus metoclopramide and thiethylperazine in patients undergoing cancer chemotherapy

artículo científico publicado el 25 de junio de 1980

The bioavailability of oral intermediate-dose methotrexate. Effect of dose subdivision, formulation, and timing in the chemotherapy cycle

scientific article published on 01 January 1984

The clinical pharmacokinetics of N-5-dimethyl-9-[(2-methoxy-4-methyl-sulfonylamino)phenylamino]-4 -acridinecarboxamide (CI-921) in a phase 1 trial

scientific article published on 01 January 1988

The effect of dose on the bioavailability of oral etoposide.

artículo científico publicado en 1986

The effect of dose on the bioavailability of oral etoposide: confirmation of a clinically relevant observation

scientific article published on 01 January 1989

The effect of food and concurrent chemotherapy on the bioavailability of oral etoposide.

artículo científico publicado en 1985

The impact of different tumour subtypes on management and survival of New Zealand women with Stage I-III breast cancer

scholarly article

The importance of bleomycin in combination chemotherapy for good-prognosis germ cell carcinoma. Australasian Germ Cell Trial Group ⬇️

artículo científico publicado el 1 de julio de 1993

The influence of cimetidine on the pharmacokinetics of 5-fluorouracil

artículo científico publicado en 1984

The management of small cell lung cancer

artículo científico publicado en 1986

The need for a national cancer control strategy in New Zealand

artículo científico publicado en 1999

The treatment of advanced recurrent carcinoma of the uterine cervix with platinum based cytotoxic chemotherapy

artículo científico publicado en 1987

The use of trastuzumab in New Zealand women with breast cancer

artículo científico publicado en 2017

Trade-offs in quality of life and survival with chemotherapy for advanced breast cancer: mature results of a randomized trial comparing single-agent mitoxantrone with combination cyclophosphamide, methotrexate, 5-fluorouracil and prednisone

artículo científico publicado en 2013

Treatment and survival disparities by ethnicity in New Zealand women with stage I-III breast cancer tumour subtypes

artículo científico publicado en 2017

Treatment of breast cancer in the Auckland region 1976-85

artículo científico publicado en 1994

Treatment of metastatic prostate carcinoma with the depot LRH analog Zoladex

scientific article published on 01 January 1988

Treatment-induced symptoms, depression and age as predictors of sexual problems in premenopausal women with early breast cancer receiving adjuvant endocrine therapy

scientific article published on 09 April 2020

Variable bioavailability following repeated oral doses of etoposide

scientific article published on 01 November 1985

Zoladex treatment of symptomatic prostatic carcinoma

scientific article published on 01 January 1988

Lista de obras de Vernon Harvey

A durable complete remission between two isolated presentations of metastatic breast cancer, the second with intracardiac disease

A phase II study of tamoxifen in ovarian cancer

A prospective study of cisplatin-based combination chemotherapy in advanced germ cell malignancy: role of maintenance and long-term follow-up

A randomized comparison of single-agent doxorubicin and epirubicin as first-line cytotoxic therapy in advanced breast cancer

A randomized phase II study comparing capecitabine alone with capecitabine and oral cyclophosphamide in patients with advanced breast cancer-cyclox II

A randomized trial comparing vindesine and cisplatinum to vindesine and methotrexate in advanced non small cell lung carcinoma

Adjuvant Letrozole and Tamoxifen Alone or Sequentially for Postmenopausal Women With Hormone Receptor-Positive Breast Cancer: Long-Term Follow-Up of the BIG 1-98 Trial

Adjuvant bevacizumab-containing therapy in triple-negative breast cancer (BEATRICE): primary results of a randomised, phase 3 trial

Adjuvant chemotherapy for non-metastatic osteosarcoma of the extremities in two New Zealand cancer centres

Adjuvant oral Razoxane (ICRF 159) in resectable colo-rectal cancer

Adjuvant therapy of colon cancer: what should we be doing

Antiemetic effect of nonabine in cancer chemotherapy

Bias in survival estimates created by a requirement for consent to enter a clinical breast cancer registry

Bilateral germ cell testicular tumors in New Zealand: experience in Auckland and Christchurch 1978-1994

Bleomycin and mild renal failure

CYP19A1 polymorphisms and clinical outcomes in postmenopausal women with hormone receptor-positive breast cancer in the BIG 1-98 trial

Capecitabine Versus Classical Cyclophosphamide, Methotrexate, and Fluorouracil As First-Line Chemotherapy for Advanced Breast Cancer

Cerebral metastases in patients with ovarian cancer treated with chemotherapy

Chemotherapy of diffuse malignant mesothelioma. Phase II trials of single-agent 5-fluorouracil and adriamycin

Cisplatin combination chemotherapy versus chlorambucil in advanced ovarian carcinoma: mature results of a randomized trial.

Clinical applications of receptor measurements in breast cancer

Clinical aspects of a phase I trial of 5,6-dimethylxanthenone-4-acetic acid (DMXAA), a novel antivascular agent

Clinical behavior of recurrent hormone receptor-positive breast cancer by adjuvant endocrine therapy within the Breast International Group 1-98 clinical trial

Cognitive function in postmenopausal breast cancer patients one year after completing adjuvant endocrine therapy with letrozole and/or tamoxifen in the BIG 1-98 trial

Cognitive function in postmenopausal women receiving adjuvant letrozole or tamoxifen for breast cancer in the BIG 1-98 randomized trial

Comparison of Subcutaneous and Intravenous Administration of Trastuzumab: A Phase I/Ib Trial in Healthy Male Volunteers and Patients With HER2-Positive Breast Cancer

Comparison of subcutaneous and intravenous administration of trastuzumab: a phase I/Ib trial in healthy male volunteers and patients with HER2-positive breast cancer

Comparison of two standard chemotherapy regimens for good-prognosis germ cell tumors: updated analysis of a randomized trial.

Comparison of two standard chemotherapy regimens for good-prognosis germ-cell tumours: a randomised trial. Australian and New Zealand Germ Cell Trial Group.

Cumulative incidence of cardiovascular events under tamoxifen and letrozole alone and in sequence: a report from the BIG 1-98 trial

Curable chemotherapy

Delayed-release bleomycin. Comparative pharmacology of bleomycin oil suspension and bleomycin in saline

Development and validation of a new predictive model for breast cancer survival in New Zealand and comparison to the Nottingham prognostic index

Differences in Breast Cancer Survival between Public and Private Care in New Zealand: Which Factors Contribute?

Disease relapse in patients with stage I nonseminomatous germ cell tumor of the testis on active surveillance

Do men undergoing sterilizing cancer treatments have a fertile future?

Dose intensity and outcome with combination chemotherapy for germ cell carcinoma. Australasian Germ Cell Trial Group

Dose-intense weekly cyclophosphamide, methotrexate, 5-fluorouracil, vincristine and prednisolone (CMFP) in advanced breast cancer

ESR1 and ESR2 polymorphisms in the BIG 1-98 trial comparing adjuvant letrozole versus tamoxifen or their sequence for early breast cancer

Effect of Adjuvant Trastuzumab for a Duration of 9 Weeks vs 1 Year With Concomitant Chemotherapy for Early Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: The SOLD Randomized Clinical Trial

Effect of dose and schedule on pharmacokinetics of high-dose cytosine arabinoside in plasma and cerebrospinal fluid

Effect of pregnancy on overall survival after the diagnosis of early-stage breast cancer.

Effective salvage chemotherapy with etoposide, dactinomycin, and methotrexate in refractory germ cell cancer. Australasian Germ Cell Trial Group

Effects of CI-921, an analogue of amsacrine, on advanced Lewis lung tumours in mice: relevance to clinical trials

Ethnic disparities in breast cancer survival in New Zealand: which factors contribute?

Evaluating and designing cancer chemotherapy treatment using mathematical models.

Experience with an implantable venous access system for chemotherapy

Follow up of breast cancer patients

Gefitinib treatment in hormone-resistant and hormone receptor-negative advanced breast cancer.

Guidelines for the use of granulocyte colony stimulating factor (G-CSF)

HCG--choosing the best assay to monitor gestational trophoblastic disease and other germ cell tumours

High-performance liquid chromatography of etoposide in plasma and urine

Improving the quality of life during chemotherapy for advanced breast cancer. A comparison of intermittent and continuous treatment strategies.

Late results of surveillance of clinical stage I nonseminoma germ cell testicular tumours: 17 years' experience in a national study in New Zealand

Late seminomatous relapse of a mixed germ cell tumor of the testis on intensive surveillance

Long-term efficacy analysis of the randomised, phase II TRYPHAENA cardiac safety study: Evaluating pertuzumab and trastuzumab plus standard neoadjuvant anthracycline-containing and anthracycline-free chemotherapy regimens in patients with HER2-posit

Maternal transmission of hepatocellular carcinoma

Medical resource utilization for administration of trastuzumab in a New Zealand oncology outpatient setting: a time and motion study

Mitozantrone-induced onycholysis.

Neratinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer (ExteNET): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

Oncology Centre--a medical view

Ondansetron reduces chemotherapy induced nausea and vomiting refractory to standard antiemetics

Overall survival benefit for sequential doxorubicin–docetaxel compared with concurrent doxorubicin and docetaxel in node-positive breast cancer—8-year results of the Breast International Group 02-98 phase III trial†

Overall survival from breast cancer in women pregnant or lactating at or after diagnosis. Auckland Breast Cancer Study Group

PIK3CA alterations and benefit with neratinib: analysis from the randomized, double-blind, placebo-controlled, phase III ExteNET trial

PO6 Consolidation of the four New Zealand breast cancer registers

Palliation of biliary obstruction in patients with advanced breast cancer using endoscopic stents ⬇️

Patient assessment of a combined medical and nursing preparation to cytotoxic chemotherapy

Pertuzumab plus trastuzumab in combination with standard neoadjuvant anthracycline-containing and anthracycline-free chemotherapy regimens in patients with HER2-positive early breast cancer: a randomized phase II cardiac safety study (TRYPHAENA)

Phase I study of the cytotoxic agent N-[2-(dimethylamino)ethyl]acridine-4-carboxamide

Phase I trial of the amsacrine analogue 9-[( 2-methoxy-4-[(methylsulfonyl)amino]-phenyl]amino)-N,5-dimethyl-4- acridinecarboxamide (CI-921)

Phase II study of efficacy, safety, and pharmacokinetics of trastuzumab monotherapy administered on a 3-weekly schedule

Phase II study of the amsacrine analogue CI-921 (NSC 343499) in non-small cell lung cancer

Phase II study of vinblastine and bleomycin in advanced ovarian cancer

Phase II trial of procarbazine, vincristine and lomustine (POC) chemotherapy in metastatic cutaneous malignant melanoma

Phase III Trial Comparing Three Doses of Docetaxel for Second-Line Treatment of Advanced Breast Cancer

Predicting nonadherence to adjuvant endocrine therapy in women with early stage breast cancer

Pregnancy after treatment of endodermal sinus tumour. Case report with five-year survival

Pregnancy and breast cancer